<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02640456</url>
  </required_header>
  <id_info>
    <org_study_id>51440</org_study_id>
    <nct_id>NCT02640456</nct_id>
  </id_info>
  <brief_title>Microbiology of Para- og Retropharyngeal Abscess</brief_title>
  <official_title>Mikrobiologi Ved Para- og Retropharyngeal Absces</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tejs Ehlers Klug</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospitalsenheden Vest</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aalborg Universitetshospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sygehus Lillebaelt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Statens Serum Institut</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of the study are:

        1. Explore the bacteriology of para- and retropharyngeal abscess.

        2. Validate the bacterial findings by exploring antibody development against F.
           necrophorum, F. nucleatum and S. pyogenes.

        3. Compare bacteriologic findings in concomitant peritonsillar and parapharyngeal
           abscesses.

        4. Characterize patients with para- and retropharyngeal abscess.

        5. Compare the concentration of amylase in para- and retropharyngeal abscesses and neck
           abscesses without relation to the pharynx or salivary glands.

        6. Perform gene-sequencing of F. Necrophorum strains, and compare these with strains
           recovered from patients with acute tonsillitis, peritonsillar abscess, and LemierreÂ´s
           syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients:

      Sixty patients aged 18 years or older with para- or retropharyngeal abscess and 12 patients
      with neck abscess without relation to the pharynx or salivary glands (controls) will be
      included at five Danish centers. Estimated time of inclusion: Four years.

      Data:

      Symptoms, findings, and other relevant information will be obtained at admission. Data
      regarding treatment and complications will be obtained after discharge.

      Samples:

        1. Tonsillar surface swabs (bilaterally)

        2. Pus aspirate from para- or retropharyngeal abscess

        3. Pus aspirate from peritonsillar abscess, if present

        4. Biopsy or the entire tonsil (bilaterally)

        5. Blood samples (acute and convalescent)

      Investigations:

        1. Bacterial cultures from tonsillar surface swabs, pus aspirates, and tonsillar tissues.

        2. Antibody development against F. necrophorum, F. nucleatum and S. pyogenes from the two
           sera.

        3. Gene-sequencing of F. Necrophorum strains.

        4. Measurement of amylase concentrations in pus aspirates.

      Power calculations:

      Patients needed to show significant increase in anti-F. necrophorum antibody development.

      Assumptions:

        1. The found anti-F. necrophorum antibody levels will be compared to previous findings in
           electively tonsillectomized patients (9 of 47 patients had two-fold or higher increase
           in anti-F. necrophorum antibody levels).

        2. Level of statistical significance: P = 0.05

        3. Power: 90%.

        4. Part of F. necrophorum-positive para- or retropharyngeal patients WHO develop two-fold
           or higher anti-F. necrophorum antibody levels: 73%.

        5. Part of para- or retropharyngeal patients with F. necrophorum: 20%. Number of para- or
           retropharyngeal patients needed: 60.

      Concerning comparison of amylase concentrations between patients with para- or
      retropharyngeal abscess and patients with neck abscesses without relation to the pharynx or
      salivary glands:

      Assumptions:

        1. Amylase concentration &gt; 20 U/L in 0% of controls.

        2. Amylase-concentration &gt; 20 U/L in 50% af patients with para- or retropharyngeal abscess
           .

        3. Inclusion of controls 1:3 compared to patients with para- or retropharyngeal abscess .

        4. Level of statistical significance: P = 0.05

        5. Power: 90%. Number of para- or retropharyngeal patients needed: 36. Number of controls
           needed: 12.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bacterial findings in aerobic and anaerobic cultures and MALDI-TOF mass spectrometry from para- and retropharyngeal abscesses</measure>
    <time_frame>Within eight hours of patient admission</time_frame>
    <description>Prevalence of potential bacterial pathogens (F. necrophorum, F. nucleatum, Prevotella species, Group A streptococcus, Group C/G streptococcus (large colony forming), S. aureus, H. influenzae, and Viridans streptococci) recovered from aerobic and anaerobic bacterial cultures from pus aspirates.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Antibody Development against F. necrophorum, F. nucleatum, and S. pyogenes in patients with para- and retropharyngeal abscess</measure>
    <time_frame>Within eight hours of patient admission (serum 1) and two to four weeks after admission (serum 2)</time_frame>
    <description>Prevalence of patients with antibody development (at least two-fold increase of antibody level) against selected bacteria (F. necrophorum, F. nucleatum, and Group A streptococci)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amylase concentrations in para- and retropharyngeal abscesses vs neck abscesses without relation to the pharynx or salivary glands</measure>
    <time_frame>Within eight hours of patient admission.</time_frame>
    <description>Comparison of amylase concentration i pus aspirates between patients with para- and retropharyngeal abscess versus patients with neck abscess not related to the pharynx or salivary glands (controls).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of bacterial recoveries in aerobic and anaerobic cultures from patients with concomitant peritonsillar and para-retropharyngeal abscess.</measure>
    <time_frame>Within eight hours of patient admission.</time_frame>
    <description>Comparison of prevalence of potential bacterial pathogens (F. necrophorum, F. nucleatum, Prevotella species, Group A streptococcus, Group C/G streptococcus (large colony forming), S. aureus, H. influenzae, and Viridans streptococci) recovered from aerobic and anaerobic bacterial cultures from pus aspirates between concomitant peritonsillar and para-retropharyngeal abscesses.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Retropharyngeal Abscess</condition>
  <arm_group>
    <arm_group_label>Para- or retropharyngeal abscess</arm_group_label>
    <description>Patients with para- or retropharyngeal abscess.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neck abscess</arm_group_label>
    <description>Patients with neck abscess without relation to the pharynx or salivary glands.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Bacteriology</intervention_name>
    <description>Tonsillar surface swabs, tonsillar tissues, and pus aspirates.</description>
    <arm_group_label>Para- or retropharyngeal abscess</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Type of surgery</intervention_name>
    <description>Surgical approach and complications.</description>
    <arm_group_label>Para- or retropharyngeal abscess</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Biochemistry</intervention_name>
    <description>Amylase concentration i pus aspirates.</description>
    <arm_group_label>Para- or retropharyngeal abscess</arm_group_label>
    <arm_group_label>Neck abscess</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Serology</intervention_name>
    <description>Levels of antibodies against selected bacteria (F. necrophorum, F. nucleatum, and Group A streptococci) in acute and convalescent sera.</description>
    <arm_group_label>Para- or retropharyngeal abscess</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tonsillar surface swabs, pus aspirates, tonsillar tissues, sera
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Sixty patients with para- or retropharyngeal abscess. Twelve patients with neck abscess
        without relation to the pharynx or salivary glands (controls).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  para- or retropharyngeal abscess

        Exclusion Criteria:

          -  refuse to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tejs E Klug, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tejs E Klug, MD</last_name>
    <phone>+45 51604046</phone>
    <email>tejklu@rm.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aalborg University Hospital</name>
      <address>
        <city>Aalborg</city>
        <zip>9100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mirjana Ninn-Pedersen, MD</last_name>
      <phone>+45 40931367</phone>
      <email>mirjananinn@yahoo.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tejs E Klug, MD</last_name>
      <phone>+45 51604046</phone>
      <email>tejklu@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospitalsenheden Vest</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Loiuse B Christensen, MD</last_name>
      <phone>+45 29932046</phone>
      <email>Anne.Louise.Christensen@auh.rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anette D Kjeldsen, PhD</last_name>
      <phone>+45 23379822</phone>
      <email>anette.kjeldsen@rsyd.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sygehus Lillebaelt</name>
      <address>
        <city>Vejle</city>
        <zip>7100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soren Fast, MD</last_name>
      <email>Soeren.Fast1@rsyd.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2015</study_first_submitted>
  <study_first_submitted_qc>December 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2015</study_first_posted>
  <last_update_submitted>April 26, 2016</last_update_submitted>
  <last_update_submitted_qc>April 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital</investigator_affiliation>
    <investigator_full_name>Tejs Ehlers Klug</investigator_full_name>
    <investigator_title>Consultant, associate professor</investigator_title>
  </responsible_party>
  <keyword>retropharyngeal abscess</keyword>
  <keyword>parapharyngeal abscess</keyword>
  <keyword>peritonsillar abscess</keyword>
  <keyword>bacteriology</keyword>
  <keyword>Fusobacterium necrophorum</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abscess</mesh_term>
    <mesh_term>Retropharyngeal Abscess</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

